Skip to main content

Get the latest public health information from CDC

Clinicalinfo.HIV.gov logo.
In affiliation with HIV.gov
Main navigation
  • Home
  • About
  • Guidelines
  • Drug Database
  • Glossary
  • News
  • Mobile Application
  • Resources
  • Contact Us
  • English
  • Español (Spanish)

Language:

  • English
  • Español

clinicalinfo.hiv.gov

Offering Information on HIV/AIDS Treatment, Prevention, and Research

Guidance for Covid-19 and People with HIV is now available.

See Guidance 

Clinical Guidelines

Federally approved medical practice guidelines for HIV/AIDS.
Guidelines 

Drug Database

Information on FDA-approved HIV/AIDS and opportunistic infection drugs and investigational HIV/AIDS drugs. Drugs 

Glossary

Medical dictionary of HIV-related terms.
Glossary 

Resources

HIV-related resources from the National Institutes of Health.
Resources 

Mobile Application

Mobile App Information 
Our website, Clinicalinfo.HIV.gov, is now optimized for mobile browsing. Therefore, the Clinicalinfo mobile application will sunset on December 30, 2022.


 

 

Entry and Fusion Inhibitors

  • Read more about Entry and Fusion Inhibitors

Protease Inhibitors (PIs)

  • Read more about Protease Inhibitors (PIs)

Non-Nucleoside Analogue Reverse Transcriptase Inhibitors (NNRTIs)

  • Read more about Non-Nucleoside Analogue Reverse Transcriptase Inhibitors (NNRTIs)

Nucleoside and Nucleotide Analogue Reverse Transcriptase Inhibitors (NRTIs)

  • Read more about Nucleoside and Nucleotide Analogue Reverse Transcriptase Inhibitors (NRTIs)

Overview

  • Read more about Overview

Antiretroviral Treatment Interruption in Children with HIV

  • Read more about Antiretroviral Treatment Interruption in Children with HIV

Recognizing and Managing Antiretroviral Treatment Failure

  • Read more about Recognizing and Managing Antiretroviral Treatment Failure

Modifying Antiretroviral Regimens in Children with Sustained Virologic Suppression on Antiretroviral Therapy

  • Read more about Modifying Antiretroviral Regimens in Children with Sustained Virologic Suppression on Antiretroviral Therapy

Overview

  • Read more about Overview

Rash and Hypersensitivity Reactions

  • Read more about Rash and Hypersensitivity Reactions

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Current page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • …
  • Next page Next ›
  • Last page Last »

CONNECT WITH US

Facebook
Twitter
Instagram
Email Updates

Footer menu

  • Home
  • About
  • Guidelines
  • Drug Database
  • Glossary
  • News
  • Mobile Application
  • Resources
  • Contact Us
  • Privacy Policy
  • Sponsors
  • Nondiscrimination Notice
  • Disclaimers
  • Accessibility
  • HHS Vulnerability Disclosure

External links

  • HIVinfo.NIH.gov
  • HHS.gov
  • NIH.gov
  • Players & Viewers
  • HHS 508
  • HHS Privacy Policy
  • Whitehouse.gov
  • USA.gov
  • Freedom of Information Act

Provided in collaboration with NIH’s Office of AIDS Research.